President Donald Trump has called on the Federal Reserve to lower interest rates, claiming inflation is no longer a concern. However, a stronger-than-expected April jobs report has made a rate cut less
MoreCrypto app developers can now bypass Apple’s restrictive App Store payment system, following a decisive court ruling that found Apple in violation of a previous antitrust injunction. This marks a significant moment
MoreArizona will not be adding Bitcoin to its portfolio of official state investments, following a veto by Governor Katie Hobbs that blocked a bill aimed at integrating crypto into the state’s financial
MoreIn a move that could significantly reshape digital gaming regulations, the United Arab Emirates (UAE) and New Jersey have entered a collaborative agreement focusing on cybersecurity, player protection, and responsible innovation. A
MoreRecent updates to the Malta Gaming Authority’s (MGA) audit and compliance procedures sparked confusion among licensed providers. The introduction of new statuses in its online system raised questions across the gaming industry,
MoreLegendary jockey Frankie Dettori is making headlines once again—this time outside the saddle—as he becomes the first-ever Horseracing Ambassador for betting platform Stake. This new role will see Dettori engage in multiple
MoreDespite recording a staggering $4.2 billion net loss in Q1 2025, Strategy is doubling down on its aggressive Bitcoin acquisition strategy, planning to raise $21 billion through an at-the-market equity offering. Unrealized
MoreChipmaking giant Qualcomm has joined the growing list of tech companies expressing concern over the economic effects of U.S. trade policy. On Wednesday, the company issued a forecast for its third-quarter earnings
MoreMajor League Baseball (MLB) is seeing rising interest from private equity firms as the sport navigates a shifting landscape in player salaries, media rights, and long-term financial strategy. While baseball has historically
MorePfizer has revealed plans to boost its cost-saving measures by an additional $1.7 billion, focusing on its manufacturing and R&D operations. The announcement came as the pharmaceutical giant reported a dip in
More
